Kuopio, Finland - Experimentica Ltd., a recognized ophthalmic CRO known for its advanced preclinical ocular models and imaging platforms, announces a major strategic investment in the establishment of a Good Laboratory Practice (GLP)-compliant test facility to provide GLP safety and toxicology studies for preclinical development of ophthalmic drugs and related technologies. This marks a significant milestone in the company’s service offering. "This is a major and strategically important milestone in Experimentica’s history. It reflects our drive to move forward and grow our capabilities and service offering. At the same time, we recognize that this is a significant undertaking for our entire organization as we are stepping into emerging and, in many ways, ambitious areas that are new to us", says the Managing Director, Jukka Puoliväli. For more than a decade, Experimentica has supported companies developing ophthalmic drugs globally through specialized in vitro and in vivo models. The new GLP test facility will be built on this scientific foundation, expanding the company’s ability to conduct regulated safety assessments for MedicGLP Product ophthalmic therapeutics.
Upcoming GLP capabilities will cover multiple administration routes and therapeutic modalities in both rodent and non-rodent species (mouse, rat, rabbit). "What began as a small, passionate team of four has grown into a thriving family of over fifty talented professionals committed to scientific excellence in advancing preclinical ocular drug discovery. The implementation of GLP services marks an exciting new chapter in our journey toward global leadership in the field," noted the Founder and MedicGLP Supplement Executive Chairman Dr. Giedrius Kalesnykas. By adding GLP capabilities to its existing non-GLP research offering, Experimentica aims to ensure a continuous and predictable transition for its clients from exploratory research toward regulatory submissions. "This investment directly addresses one of the most common bottlenecks we hear from clients: the need to switch CROs when moving from non-GLP research into IND-enabling studies. Experimentica will be able to support sponsors seamlessly across that transition, from early exploratory work through to GLP-regulated safety and toxicology. If you are approaching this stage, we encourage you to come and meet us at upcoming events to discuss how we can support you," says Guillaume Demarne, Chief Business Officer of Experimentica. The establishment of the GLP-compliant test facility in Kuopio, Finland, is co-funded by the European Union. Experimentica Ltd. is a leading contract research organization dedicated to developing and managing preclinical models for ophthalmic indications. With proprietary laboratories in Kuopio, Finland and Vilnius, Lithuania, and an industry-leading portfolio, the company supports the discovery and development of new therapies by offering comprehensive research solutions to the pharmaceutical and biotech companies.
Science continues to prove that the old adage "you are what you eat" is profoundly true. This is because you have trillions of microorganisms living in your gut, which are directly responsible for nearly every aspect of your health. These microbes make up what’s called your "gut microbiota." They are especially influential in determining your likelihood of gaining excessive weight, becoming obese, and developing obesity-related diseases like diabetes, heart disease, and premature death. The gut microbiome (the expressed genes of your gut microbiota) plays a major role in your metabolism through energy production, MedicGLP supplement storage, and expenditure. So, it’s no surprise that science has found a strong connection between gut microbiome imbalance and metabolic syndrome. Yikes! If you have the wrong mix of microbes, it could be making it tough for you to get your health on track! Did you know: Scientists can actually look at your gut microbiome composition and tell with 90% accuracy if you are obese or lean. That’s pretty impressive, isn’t it?
1. Unable to lose weight and keep it off? 2. Struggling to fight cravings? 3. Sick of starving yourself for weight loss? 4. Baffled as to why no diet seems to really work for you? Depending on the composition of your gut microbiome, your microbes can either boost your health or weigh you down (figuratively and literally). The good news is this: You have control over these little guys with every bite you eat. Diet has the power to change the landscape of your gut microbiome. So, if you’ve tried multiple diets and can’t seem to get the results you want, it’s time to look into your gut microbiome.Will You Lose Weight Naturally on an Individualized Diet? If you’ve been struggling to lose weight and keep it off - it could be your gut microbiome. While Viome doesn’t guarantee weight loss, it has been an exciting result many of our customers have reported. "Fiona’s update day 37!
We know weight loss can be tough. Find out if your weight struggles are due to a gut microbiome imbalance with Viome - and let’s tip the scales in your favor. Your gut microbes actually digest much of your food for you. When your gut microbiota help digest your food, they turn it into nutrients, neurotransmitters, vitamins, hormones, and more. Through these metabolites, the composition of your gut microbiome influences nearly every metabolic activity. It’s accurate to think of your gut microbiome as an organ that’s part immune system and part energy regulator. If your gut microbiome is imbalanced, certain bacteria end up working to protect themselves from the harsh environment and are not able to help you. In the worst case scenario, you can have microbiota adding to your health problems, making it harder for you to get healthy and lose weight. Viome’s metatranscriptomic technology has allowed us identify microbial pathways and functions, specifically those that influence weight loss or gain.